These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24511294)

  • 1. Identification of p53 and its isoforms in human breast carcinoma cells.
    Milićević Z; Bajić V; Živković L; Kasapović J; Andjelković U; Spremo-Potparević B
    ScientificWorldJournal; 2014; 2014():618698. PubMed ID: 24511294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative regulation of chemokine receptor CXCR4 by tumor suppressor p53 in breast cancer cells: implications of p53 mutation or isoform expression on breast cancer cell invasion.
    Mehta SA; Christopherson KW; Bhat-Nakshatri P; Goulet RJ; Broxmeyer HE; Kopelovich L; Nakshatri H
    Oncogene; 2007 May; 26(23):3329-37. PubMed ID: 17130833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoplasmic p53β Isoforms Are Associated with Worse Disease-Free Survival in Breast Cancer.
    Steffens Reinhardt L; Groen K; Morten BC; Bourdon JC; Avery-Kiejda KA
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743117
    [No Abstract]   [Full Text] [Related]  

  • 4. P53 protein accumulation in non-invasive lesions surrounding p53 mutation positive invasive breast cancers.
    Done SJ; Arneson CR; Ozçelik H; Redston M; Andrulis IL
    Breast Cancer Res Treat; 2001 Jan; 65(2):111-8. PubMed ID: 11261826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.
    Alsner J; Jensen V; Kyndi M; Offersen BV; Vu P; Børresen-Dale AL; Overgaard J
    Acta Oncol; 2008; 47(4):600-7. PubMed ID: 18465328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maintenance of p53 alterations throughout breast cancer progression.
    Davidoff AM; Kerns BJ; Iglehart JD; Marks JR
    Cancer Res; 1991 May; 51(10):2605-10. PubMed ID: 1850660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 mutations and expression in breast carcinoma in situ.
    Lukas J; Niu N; Press MF
    Am J Pathol; 2000 Jan; 156(1):183-91. PubMed ID: 10623666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relative mRNA expression of p53 isoforms in breast cancer is associated with clinical features and outcome.
    Avery-Kiejda KA; Morten B; Wong-Brown MW; Mathe A; Scott RJ
    Carcinogenesis; 2014 Mar; 35(3):586-96. PubMed ID: 24336193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines.
    Bartek J; Iggo R; Gannon J; Lane DP
    Oncogene; 1990 Jun; 5(6):893-9. PubMed ID: 1694291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutant breast cancer patients expressing p53γ have as good a prognosis as wild-type p53 breast cancer patients.
    Bourdon JC; Khoury MP; Diot A; Baker L; Fernandes K; Aoubala M; Quinlan P; Purdie CA; Jordan LB; Prats AC; Lane DP; Thompson AM
    Breast Cancer Res; 2011 Jan; 13(1):R7. PubMed ID: 21251329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant p53 accumulation in human breast cancer is not an intrinsic property or dependent on structural or functional disruption but is regulated by exogenous stress and receptor status.
    Bouchalova P; Nenutil R; Muller P; Hrstka R; Appleyard MV; Murray K; Jordan LB; Purdie CA; Quinlan P; Thompson AM; Vojtesek B; Coates PJ
    J Pathol; 2014 Jul; 233(3):238-46. PubMed ID: 24687952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro.
    Bártek J; Bártková J; Vojtĕsek B; Stasková Z; Rejthar A; Kovarík J; Lane DP
    Int J Cancer; 1990 Nov; 46(5):839-44. PubMed ID: 2228312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of p53/Mieap-regulated mitochondrial quality control as a tumor suppressor in human breast cancer.
    Gaowa S; Futamura M; Tsuneki M; Kamino H; Tajima JY; Mori R; Arakawa H; Yoshida K
    Cancer Sci; 2018 Dec; 109(12):3910-3920. PubMed ID: 30290054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 Dysregulation in Breast Cancer: Insights on Mutations in the
    Steffens Reinhardt L; Groen K; Xavier A; Avery-Kiejda KA
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear image analysis of p53-positive and -negative cells in breast carcinoma.
    Friedrich K; Thieme B; Haroske G; Meyer W; Dimmer V; Theissig F; Kunze KD
    Anal Quant Cytol Histol; 1997 Aug; 19(4):285-93. PubMed ID: 9267561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 isoforms can regulate p53 transcriptional activity.
    Bourdon JC; Fernandes K; Murray-Zmijewski F; Liu G; Diot A; Xirodimas DP; Saville MK; Lane DP
    Genes Dev; 2005 Sep; 19(18):2122-37. PubMed ID: 16131611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of nuclear accumulation of p53 protein with mutations in the p53 gene on the tissues of human breast cancer].
    Fan P; Wu Z; Cha X; Wang X; Wang S
    Zhonghua Wai Ke Za Zhi; 1998 Nov; 36(11):655-7. PubMed ID: 11825490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The RNA helicase p68 modulates expression and function of the Δ133 isoform(s) of p53, and is inversely associated with Δ133p53 expression in breast cancer.
    Moore HC; Jordan LB; Bray SE; Baker L; Quinlan PR; Purdie CA; Thompson AM; Bourdon JC; Fuller-Pace FV
    Oncogene; 2010 Dec; 29(49):6475-84. PubMed ID: 20818423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to malignant breast disease.
    Eriksson ET; Schimmelpenning H; Aspenblad U; Zetterberg A; Auer GU
    Hum Pathol; 1994 Nov; 25(11):1228-33. PubMed ID: 7959668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic identification of heat shock protein 90 as a candidate target for p53 mutation reactivation by PRIMA-1 in breast cancer cells.
    Rehman A; Chahal MS; Tang X; Bruce JE; Pommier Y; Daoud SS
    Breast Cancer Res; 2005; 7(5):R765-74. PubMed ID: 16168122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.